Biosimilars Guidance, Drugmaker Grades Coming, FDA Says

Biosimilars guidance will be out within one year, a Consumer Reports-style scorecard may soon describe drug manufacturing quality and companies shouldn't despair if regulators decline requests to meet about product development,...

Already a subscriber? Click here to view full article